Glendenning P - Search Results

1

Effects of three-monthly oral 150,000 IU cholecalciferol supplementation on falls, mobility, and muscle strength in older postmenopausal women: a randomized controlled trial.

Glendenning P, Zhu K, Inderjeeth C, Howat P, Lewis JR, Prince RL. Glendenning P, et al. J Bone Miner Res. 2012 Jan;27(1):170-6. doi: 10.1002/jbmr.524. J Bone Miner Res. 2012. PMID: 21956713 Free article. Clinical Trial.

2

Calcitriol upregulates expression and activity of the 1b isoform of the plasma membrane calcium pump in immortalized distal kidney tubular cells.

Glendenning P, Ratajczak T, Dick IM, Prince RL. Glendenning P, et al. Arch Biochem Biophys. 2000 Aug 1;380(1):126-32. doi: 10.1006/abbi.2000.1908. Arch Biochem Biophys. 2000. PMID: 10900141

3

The promoter region of the human PMCA1 gene mediates transcriptional downregulation by 1,25-dihydroxyvitamin D(3).

Glendenning P, Ratajczak T, Prince RL, Garamszegi N, Strehler EE. Glendenning P, et al. Biochem Biophys Res Commun. 2000 Nov 2;277(3):722-8. doi: 10.1006/bbrc.2000.3745. Biochem Biophys Res Commun. 2000. PMID: 11062020

4

Regulation of the 1b isoform of the plasma membrane calcium pump by 1,25-dihydroxyvitamin D3 in rat osteoblast-like cells.

Glendenning P, Ratajczak T, Dick IM, Prince RL. Glendenning P, et al. J Bone Miner Res. 2001 Mar;16(3):525-34. doi: 10.1359/jbmr.2001.16.3.525. J Bone Miner Res. 2001. PMID: 11277270 Free article.

5

Estrogen and androgen regulation of plasma membrane calcium pump activity in immortalized distal tubule kidney cells.

Dick IM, Liu J, Glendenning P, Prince RL. Dick IM, et al. Among authors: glendenning p. Mol Cell Endocrinol. 2003 Dec 30;212(1-2):11-8. doi: 10.1016/j.mce.2003.09.028. Mol Cell Endocrinol. 2003. PMID: 14654246

6

8: Disorders of bone and mineral other than osteoporosis.

Prince RL, Glendenning P. Prince RL, et al. Among authors: glendenning p. Med J Aust. 2004 Apr 5;180(7):354-9. doi: 10.5694/j.1326-5377.2004.tb05977.x. Med J Aust. 2004. PMID: 15059059 Review.

7

Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: review of the evidence.

Inderjeeth CA, Foo AC, Lai MM, Glendenning P. Inderjeeth CA, et al. Among authors: glendenning p. Bone. 2009 May;44(5):744-51. doi: 10.1016/j.bone.2008.12.003. Epub 2008 Dec 16. Bone. 2009. PMID: 19130909 Review.

8

Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol.

Glendenning P, Chew GT, Seymour HM, Gillett MJ, Goldswain PR, Inderjeeth CA, Vasikaran SD, Taranto M, Musk AA, Fraser WD. Glendenning P, et al. Bone. 2009 Nov;45(5):870-5. doi: 10.1016/j.bone.2009.07.015. Epub 2009 Jul 23. Bone. 2009. PMID: 19631774 Clinical Trial.

9

Association between 25-hydroxyvitamin D, somatic muscle weakness and falls risk in end-stage renal failure.

Boudville N, Inderjeeth C, Elder GJ, Glendenning P. Boudville N, et al. Among authors: glendenning p. Clin Endocrinol (Oxf). 2010 Sep;73(3):299-304. doi: 10.1111/j.1365-2265.2010.03821.x. Epub 2010 Apr 30. Clin Endocrinol (Oxf). 2010. PMID: 20507339

10

Efficacy, side effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009.

Lee S, Glendenning P, Inderjeeth CA. Lee S, et al. Among authors: glendenning p. Osteoporos Int. 2011 Mar;22(3):741-53. doi: 10.1007/s00198-010-1335-x. Epub 2010 Jun 30. Osteoporos Int. 2011. PMID: 20589368 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters